Barbervax®: giving blood-sucking parasitic worms a taste of their own medicine
This case study is part of a series focusing on the importance of sustained funding for fundamental and strategic research. The first in this series summarises the research behind Barbervax®: a vaccine for the Barber’s Pole Worm, Haemonchus contortus. Barbervax® is the first vaccine in the world for a worm parasite of sheep and for a gut-dwelling worm of any host, including man.